What happened to 23andMe? | CNN Business
WEB2 days ago · A version of this story appeared in CNN Business’ Nightcap newsletter. To get it in your inbox, sign up for free, here. New York CNN — The history of DNA-testing startup 23andMe reads like a ...
23andMe directors resign as CEO seeks to take genetic ... - CBS News
WEB2 days ago · PIX Now morning edition 9-20-24 11:09. All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company.
23andMe independent directors resign from board: Read the CEO …
WEB6 days ago · Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023. All seven independent ...
23andMe Directors Resign as the CEO of the Genetic-Testing …
WEB3 days ago · Last week, 23andMe agreed to pay $30 million in cash to settle a class-action lawsuit accusing the company of failing to protect customers whose personal information was exposed in a 2023 data breach.
23andMe Therapeutics Announces Phase 2 Results for Two …
WEBSUNNYVALE, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, announced positive preliminary Phase 2 safety and efficacy data from its Phase 1/2a clinical trial covering two new patient cohorts from 23ME-00610 (’610), a first-in-class anti ...
23andMe Is Under Fire. Its Founder Remains ‘Optimistic’
WEBFeb 12, 2024 · Valued at $6 billion in 2021 when it went public, 23andMe now risks being delisted from the Nasdaq as its stock continues to trade below $1 a share. And like many Silicon Valley startups, it’s...
Data Breach at 23andMe Affects 6.9 Million Profiles, Company Says
WEBDec. 4, 2023. Hackers, using old passwords from customers of the genetic testing company 23andMe, were able to gain access to personal information from about 6.9 million profiles, which in some...
Press Releases - 23andMe, Inc.
WEBAug 1, 2024 · 23andMe Reports First Quarter Fiscal 2025 Financial Results. SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the first quarter of fiscal year 2025 (FY25), which ended June 30, 2024. August 8, 2024.
23andMe is low on cash and its stock is worth pennies. The CEO …
WEBFeb 2, 2024 · New York CNN — Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Silicon Valley. Today, the firm is at risk of being delisted from the Nasdaq. But...
23andMe Breach Targeted Jewish and Chinese Customers, …
WEBJan 26, 2024 · The genetic testing company 23andMe is being accused in a class-action lawsuit of failing to protect the privacy of customers whose personal information was exposed last year in a data breach...
- Some results have been removed